Free Newsletters | Help  

  Business | Food/Beverage | NEW Products | Retail | Events | Practitioner | Personal Care | Careers & Recruiting | Reports
Crossfire - issues and hot topics
Login ID:    Password:    Register for a FREE account
 NEWS

Industry News
Business
Organic
Food & Beverage
Sports Nutrition
Nutraceuticals
Regulatory
Research
Products
Practitioners
Retail
Events
People
On-line


 LISTINGS
  Categories
Products

Profiles
Publishers

 OPINION
  Editorials
Interviews
Up and Comers
Quality Initiatives
Discussions

 
Marc Ullman FYI Blog
Len Monheit Off The Cuff
Analytical/testing
Jim Lassiter -- Good News/Bad News
The Nutrition Business Journal Blog

 FEATURES
 

 Newsletter

  News Feeds
XML icon
 
 SERVICES
  Log in
Register User
Add Company

Career Center
Discussions

Advertise
 INFO CENTER
  Help
Contact Us
About NPI
Privacy Policy



Advertisement


 
  More Immune Health Science
  • Study Finds Biothera's Imprime PGG Increases Efficacy of Erbitux against Non-Small Cell Lung Cancer
    [2007/09/11] [Biothera]
    Preclinical research published in Cancer Research, suggests that Imprime PGG(TM) may increase the efficacy of Erbitux(R) for the treatment of non-small cell lung cancer and potentially other cancers that express epidermal growth factor receptor (EGFR) on their cell surface.
  • GTC Nutrition Announces Three New Published Studies on NutraFlora scFOS® Prebiotic Fiber
    [2007/08/25] [GTC Nutrition]
    GTC Nutrition today announced the publication of three new studies relating to NutraFlora® short-chain fructooligosaccharides (scFOS®) prebiotic fiber and immune health. These studies are published in the World Journal of Gastroenterology, Journal of Animal Physiology and Animal Nutrition and the Journal of Agricultural and Food Chemistry.
  • Study Finds Biothera Compounds Enhance Human Immune Cell Function
    [2007/05/08] [Biothera]
    Researchers at Rhode Island Hospital and the Warren Alpert Medical School at Brown University measured the ability of human neutrophils to kill filamentous Candida albicans, determining that Biothera’s yeast-derived beta 1,3/1,6 glucans (Imprime PGG(TM) and WGP(R) 3-6) enhance the anti-microbial function of the neutrophils.
  • Study: Selenomax(R) Suppresses Progression of the Human Immunodeficiency Virus (HIV-1) According to Results Published in Archives of Internal Medicine
    [2007/01/23] [Nutrition 21, Inc.]
    Results of a five-year, double-blind, placebo-controlled study conducted by researchers at the University of Miami and published in the January 22 issue of the American Medical Association's Archives of Internal Medicine indicate that daily supplementation with Selenomax(R), Nutrition 21's high selenium yeast product, suppressed progression of the human immunodeficiency virus (HIV-1) and improved immune cell CD4 counts in HIV-1 seropositive men and women.
  • GliSODin study on oxidative stress in immune compromised humans included in the 2006 XVI International AIDS Conference
    [2006/08/15] [glisodin.org]
    A study on Glisodin and immune compromised individuals at the AIDS 2006 - XVI International AIDS Conference, August 13-18 2006, held in Toronto. In the study, Glisodin was shown to restore the circulating antioxidant capacities, including Superoxide Dismustase (SOD), in the Glisodin group, compared to no change in the control and placebo group.
  • Dr. Alex Schauss to Present Immune Health Research at A4M Congress
    [2006/07/06] [AIBMR Life Sciences]
    Alexander Schauss, Ph.D., FACN, will discuss the results of his study that examined the correlation between the unusually low sick rates of a controlled population of Cedar Rapids, Iowa, factory employees and their exposure to an edible fermentation product at the 14th Annual International Congress on Anti-Aging Medicine, Friday, July 14 from 3:50 – 4:50 p.m. in room #27 of the Stephens Convention Center, Chicago.
  • Probiotics From Nutraceutix Shown in Clinical Research to Enhance Immune Function
    [2006/06/02] [Nutraceutix, Inc.]
    As presented by university researchers at the North American Research Conference on Complementary and Integrative Medicine in Edmonton, probiotic tablets manufactured by Nutraceutix, Inc. were shown to enhance phagocytosis by monocytes and neutrophils in a healthy adult human population.
  • Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine
    [2005/12/01] [American Botanical Council (ABC)]
    The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit.
  • Researchers Study Colostrum’s Effect on Bacteria and Virus
    [2005/09/21] [Sterling Technology, Inc.]
    Collaborative research project between Sterling Technology, Inc. and South Dakota State University demonstrates that colostral whey concentrate has immune effect, inhibits toxins, and blocks infection.
  • NEJM Publishes Study on Low-dose Echinacea for Colds
    [2005/07/27] [American Herbal Products Association (AHPA)]
    Association comments on published study; Dose found ineffective, AHPA notes concern expressed by one of the researchers that the dose may have been too low to be effective for use in colds, suggests dose or brand selection would have improved study quality.

  • Advertisement



    Advertisement


     Health Centers

    Sponsored Links:
    Featured Links:
    New Hope Natural Media NPIcenter Address and Phone Number
    Contact Us | Privacy Policy | Terms of Use | Advertise
    Healthy Foods Conferences SUPPLYEXPO Natural Products Expo Asia

    Funtional Foods & Nutraceuticals Magazine Nutracon The Newport Summit - Executive Retreat
    Version control powered by Dynamsoft SourceAnywhere